Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision.
Gloria ZaffaroniAlessandro MannucciLaura E KoskenvuoF Borja de LacyAnna MaffioliTanya BisselingElizabeth HalfGiulia Martina CavestroLaura ValleNeil RyanStefan AretzKaren BrownFrancesco ButtittaFatima CarneiroOonagh ClaberRuth Blanco-ColinoMaxime K CollardEmma CrosbieMiguel CunhaTriantafyllos DouliasChristina FlemingHenriette HeinrichRobert HüneburgJulie MetrasIris NagtegaalIonuț NegoiMaartje NielsenGianluca PellinoLuigi RicciardielloAbdurrahman SagirLuís Sánchez-GuillénToni T SeppäläPeter SiersemaBenedikt StriebeckJulian R SampsonAndrew LatchfordYann ParcJohn BurnGabriela MoesleinPublished in: The British journal of surgery (2024)
These updated guidelines provide current, comprehensive, and evidence-based practical recommendations for the management of surveillance and treatment of familial adenomatous polyposis patients, encompassing additionally MUTYH-associated polyposis, gastric adenocarcinoma and proximal polyposis of the stomach and other recently identified polyposis syndromes based on pathogenic variants in other genes than APC or MUTYH. Due to the rarity of these diseases, patients should be managed at specialized centres.
Keyphrases
- chronic rhinosinusitis
- end stage renal disease
- ejection fraction
- chronic kidney disease
- squamous cell carcinoma
- peritoneal dialysis
- public health
- prognostic factors
- total knee arthroplasty
- gene expression
- palliative care
- genome wide
- dna methylation
- radiation therapy
- transcription factor
- patient reported outcomes
- total hip arthroplasty
- high density